×
For best experience we recommend to activate Javascript in your browser.
CCL20 antibody (AA 24-97)
This Rabbit Polyclonal antibody specifically detects CCL20 in WB, IHC, IP and ICC. It exhibits reactivity toward Mouse.
Quick Overview for CCL20 antibody (AA 24-97) (ABIN7621969)
Target
See all CCL20 Antibodies
CCL20
(Chemokine (C-C Motif) Ligand 20 (CCL20))
Reactivity
All reactivities for CCL20 antibodies
Mouse
Host
All hosts for CCL20 antibodies
Rabbit
Clonality
All clonalities for CCL20 antibodies
Polyclonal
Conjugate
All conjugates for CCL20 antibodies
This CCL20 antibody is un-conjugated
Application
All applications for CCL20 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CCL20 Antibody
(hide)
Binding Specificity
All epitopes for CCL20 antibodies
AA 24-97
Purpose
Macrophage Inflammatory Protein 3 Alpha (MIP3a) Polyclonal Antibody
Sequence
Gln24~Met97
Characteristics
The Macrophage Inflammatory Protein 3 Alpha (MIP3a) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CCL20
(hide)
Target
CCL20
(Chemokine (C-C Motif) Ligand 20 (CCL20))
Alternative Name
MIP3a
Gene ID
20297
UniProt
O89093
Pathways
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Recently viewed
(hide)
Chat with us , powered by LiveChat